Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma

Fig. 1

Pre-treatment neutrophil-to-lymphocyte ratio (NLR) and prognosis. a, b Pre-treatment NLR levels and 1-year (a) and 2-year (b) survival rates. c, d Kaplan-Meier survival curves stratified by pre-treatment NLR levels. Survival time was significantly shorter among patients with NLR ≥4 (or >2.54) than among those with NLR <4 (or ≤2.54)

Back to article page